Not finding it? Sign in to also search OpenAlex live.
-
Gammaherpesvirus infection impairs lung fibrosis resolution through PD-L1+ fibroblasts and PD-1+ CD8+ T cell interaction2026 Mucosal Immunology article Medicine Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Open access
Laura Kempen, Domien Vanneste, Justine Javaux, Lorène Dams, R Sandor, M. Pathammavong, +14 more
0citations -
Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumors2023 Molecular Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 1 patent
Philipp Knopf, Dimitri Stowbur, Sabrina H. L. Hoffmann, Natalie Hermann, Andreas Maurer, Valentina Bucher, +23 more
88citations -
Anti-PD-1 antibody increases NK cell cytotoxicity towards nasopharyngeal carcinoma cells in the context of chemotherapy-induced upregulation of PD-1 and PD-L12020 Cancer Immunology Immunotherapy article Immunology and Microbiology Immune Cell Function and Interaction Open access cited by 1 patent
Anna M. Makowska, Selina Meier, Lian Shen, Pierre Busson, Valentin M. D. Baloche, Udo Kontny
46citations -
PD-L1 PET/CT imaging with 18F-BMS-986,229 and 18F-BMS-986,192 in patients with advanced-stage non-small cell lung cancer2026 European Journal of Nuclear Medicine and Molecular Imaging article Medicine Cancer Immunotherapy and Biomarkers
Jasper N. Smit, Frank Johannes Borm, Nienke R. Gerards, Sanne E. Wiegers, Daniel Holden, David Leung, +10 more
0citations -
CRISPR activation screening identifies VGLL3 and GATA2 as transcriptional regulators of PD-L12021 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Cancer Immunotherapy and Biomarkers Open access
Ruud H. M. Wijdeven, Birol Cabukusta, Xueer Qiu, Daniel Borràs, Yun Liang, Jacques Neefjes
0citations -
Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients2020 Cancer Immunology Immunotherapy article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 1 patent
Daan P. Hurkmans, Merian E. Kuipers, Ronald van Marion, Ron H.J. Mathijssen, Piet E. Postmus, Pieter Sicco Hiemstra, +3 more
96citations -
Levels of Circulating PD-L1 Are Decreased in Patients with Resectable Cholangiocarcinoma2021 International Journal of Molecular Sciences article Medicine Cholangiocarcinoma and Gallbladder Cancer Studies Open access cited by 2 patents
Christoph Roderburg, Sven Heiko Loosen, Jan Bednarsch, Patrick H. Alizai, Anjali A. Roeth, Sophia M. Schmitz, +8 more
7citations -
The impact of a pathologist’s personality on the interobserver variability and diagnostic accuracy of predictive PD-L1 immunohistochemistry in lung cancer
Rogier Butter, Liesbeth M. Hondelink, Lisette van Elswijk, Johannes L.G. Blaauwgeers, Elisabeth Bloemena, Rieneke Britstra, +15 more
33citations -
Multivalent Atezolizumab-Liposome Conjugates as Active Immunotherapeutic Platforms for Enhanced PD-L1 Blockade in Melanoma2026 International Journal of Nanomedicine article Medicine Cancer Immunotherapy and Biomarkers Open access
Ziyun Cheng, Mohamadreza Amin, Mandy van Brakel, Andrea Sacchetti, Robbert Q. Kim, Ann L.B. Seynhaeve, +2 more
0citations -
Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancer2021 Journal of Translational Medicine article Medicine PARP inhibition in cancer therapy Open access cited by 1 patent
Jinyu Meng, Jin Peng, Jie Feng, Jochen Maurer, Xiao Li, Yan Li, +11 more
63citations